General Provisions Clause Example from Business Contracts
This example General Provisions clause appears in 46 contracts from 30 companies
Purchase Agreement between OncoCyte Corporation and Piper Jaffray & Co. dated February 8, 2019 (Filed With SEC on February 12, 2019)
Purchase Agreement, dated February 4, 2021, between OncoCyte Corporation and Piper Sandler & Co., as representative of the underwriters named therein (Filed With SEC on February 5, 2021)
Underwriting Agreement, dated April 17, 2019 (Filed With SEC on April 22, 2019)
Underwriting Agreement, dated as of October 23, 2018, by and between Eiger BioPharmaceuticals, Inc. and BTIG, LLC (Filed With SEC on October 23, 2018)
Underwriting Agreement, dated June 26, 2019, by and between Motus GI Holdings, Inc. and Piper Jaffray & Co., as representative (Filed With SEC on June 27, 2019)
Underwriting Agreement, dated December 19, 2018, by and between Motus GI Holdings, Inc. and Piper Jaffray & Co., as representative of the underwriters (Filed With SEC on December 20, 2018)
Form of Underwriting Agreement (Filed With SEC on December 17, 2018)
Form of Underwriting Agreement (Filed With SEC on January 31, 2018)
Purchase Agreement dated July 31, 2019 (Filed With SEC on August 2, 2019)
Underwriting Agreement, dated December 11, 2019, by and among OrthoPediatrics Corp., the Selling Stockholders and Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated,... (Filed With SEC on December 12, 2019)
Underwriting Agreement, dated June 17, 2020, by and among OrthoPediatrics Corp. and Piper Sandler & Co. and Stifel, Nicolaus & Company, Incorporated, acting as representatives of... (Filed With SEC on June 18, 2020)
Underwriting Agreement, dated August 10, 2022, by and among OrthoPediatrics Corp. and Piper Sandler & Co. and Stifel, Nicolaus & Company, Incorporated, acting as representatives... (Filed With SEC on August 12, 2022)
Underwriting Agreement, dated December 7, 2018, by and among OrthoPediatrics Corp. and Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated, acting as representatives... (Filed With SEC on December 7, 2018)
Purchase Agreement, dated November 27, 2019, by and among Aravive, Inc., Piper Jaffray & Co. and Cantor Fitzgerald & Co (Filed With SEC on November 27, 2019)
Underwriting Agreement dated December 3, 2019 by and between the Company and Piper Jaffray & Co., as representative of the several underwriters named therein (Filed With SEC on December 6, 2019)
Underwriting Agreement dated January 4, 2021 by and between the Company and Piper Sandler & Co., as representative of the several underwriters named therein (Filed With SEC on January 7, 2021)
Underwriting Agreement dated November 16, 2021 by and among the Company, Piper Sandler & Co., and Stifel, Nicolaus & Company, Incorporated, as representatives of the several... (Filed With SEC on November 19, 2021)
Underwriting Agreement, dated February 4, 2020, between Rockwell Medical, Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 6, 2020)
Underwriting Agreement, dated March 24, 2020, by and between Baudax Bio, Inc. and JMP Securities LLC, as representative of the several underwriters named therein (Filed With SEC on March 24, 2020)
Purchase Agreement, dated April 16, 2020, by and between Cutera, Inc., and Piper Sandler & Co (Filed With SEC on April 21, 2020)
Equity Distribution Agreement, dated June 5, 2020, between Independent Contract Drilling, Inc. and Piper Sandler & Co (Filed With SEC on June 5, 2020)
Form of Underwriting Agreement (Filed With SEC on June 15, 2020)
Underwriting Agreement, dated June 18, 2020, by and among Leap Therapeutics, Inc. and Piper Sandler & Co. and Raymond James & Associates, Inc., as representatives of the... (Filed With SEC on June 18, 2020)
Underwriting Agreement, dated September 22, 2021, by and among Leap Therapeutics, Inc. and Piper Sandler & Co. and Raymond James & Associates, Inc., as representatives of the... (Filed With SEC on September 22, 2021)
Form of Underwriting Agreement (Filed With SEC on January 25, 2021)
Purchase Agreement, dated January 28, 2021, by and among the Company and Piper Sandler & Co. and William Blair & Company, L.L.C. as representatives of the several Underwriters... (Filed With SEC on February 2, 2021)
Form of Underwriting Agreement (Filed With SEC on June 26, 2018)
Form of Underwriting Agreement (Filed With SEC on May 31, 2018)
Purchase Agreement, dated February 11, 2021, between Infinity Pharmaceuticals, Inc. and Piper Sandler & Co., as representative of the underwriters named therein (Filed With SEC on February 12, 2021)
Underwriting Agreement dated February 24, 2021 (Filed With SEC on March 1, 2021)
Underwriting Agreement, dated March 11, 2021 (Filed With SEC on March 16, 2021)
Form of Underwriting Agreement (Filed With SEC on November 4, 2021)
Underwriting Agreement, dated November 8, 2021, by and between MIND Technology, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 10, 2021)
Underwriting Agreement, dated November 17, 2021 (Filed With SEC on November 18, 2021)
Underwriting Agreement, dated January 23, 2023 (Filed With SEC on January 25, 2023)
Underwriting Agreement, dated November 16, 2021, by and between OptiNose, Inc. and Piper Sandler & Co (Filed With SEC on November 18, 2021)
Underwriting Agreement, dated November 21, 2022, by and between OptiNose, Inc. and Piper Sandler & Co (Filed With SEC on November 23, 2022)
Purchase Agreement, dated August 3, 2022, by and among Poseida Therapeutics, Inc., Piper Sandler & Co. and William Blair & Company, L.L.C, as representatives of the several... (Filed With SEC on August 4, 2022)
Underwriting Agreement, dated December 1, 2022, by and between Aziyo Biologics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 5, 2022)
Form of Underwriting Agreement (Filed With SEC on September 4, 2018)
Underwriting Agreement, dated August 1, 2018, by and among Del Friscos Restaurant Group, Inc. and Piper Jaffray & Co., J.P. Morgan Securities LLC and Citizens Capital Markets, Inc (Filed With SEC on August 6, 2018)
Underwriting Agreement, dated July 25, 2018, by and among Merit Medical Systems, Inc., Wells Fargo Securities, LLC, and Piper Jaffray & Co (Filed With SEC on July 30, 2018)
Underwriting Agreement, dated as of May 23, 2018, by and among Pfenex Inc. and Barclays Capital Inc. and William Blair & Company, L.L.C. as representatives of the underwriters (Filed With SEC on May 23, 2018)
Purchase Agreement, dated February 1, 2018, between OncoSec Medical Incorporated and Piper Jaffray & Co., as representatives of the several underwriters named therein (Filed With SEC on February 2, 2018)
4,000,000 Shares K2MGroup Holdings, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 1, 2017)
[ ] Shares Valeritas Holdings, Inc. Common Stock PURCHASEAGREEMENT (Filed With SEC on March 16, 2017)